-
Loading metrics
Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays
-
Christine M. Bachman ,
Contributed equally to this work with: Christine M. Bachman, Benjamin D. Grant
Roles Conceptualization, Methodology, Supervision, Writing – original draft
* E-mail: Christine.bachman@ghlabs.org
Affiliation Global Health Labs, Inc, Bellevue, Washington, United States of America
⨯ - Benjamin D. Grant ,
- Caitlin E. Anderson,
- Luis F. Alonzo,
- Spencer Garing,
- Sam A. Byrnes,
- Rafael Rivera,
- Stephen Burkot,
- Alexey Ball,
- James W. Stafford,
-
Wenbo Wang,
Roles Validation, Writing – review & editing
Affiliation Global Health Labs, Inc, Bellevue, Washington, United States of America
⨯ - Dipayan Banik,
- Matthew D. Keller,
-
David M. Cate,
Roles Conceptualization, Writing – review & editing
Current address: Amazon Dx, Seattle, Washington, United States of America
Affiliation Global Health Labs, Inc, Bellevue, Washington, United States of America
⨯ - Kevin P. Nichols,
- Bernhard H. Weigl,
- [ ... ],
- Puneet Dewan
- [ view all ]
- [ view less ]
https://orcid.org/0000-0002-8143-2782
Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays
- Christine M. Bachman,
- Benjamin D. Grant,
- Caitlin E. Anderson,
- Luis F. Alonzo,
- Spencer Garing,
- Sam A. Byrnes,
- Rafael Rivera,
- Stephen Burkot,
- Alexey Ball,
- James W. Stafford
x
- Published: August 17, 2021
- https://doi.org/10.1371/journal.pone.0256352